Publications by authors named "Ismail Akcok"

Claim this Profile
I
Identification of Potential Dual HDAC6 and HSP90 Inhibitors for the Treatment of Cancer using Molecular Docking, Molecular Dynamics and MM/PBSA Studies: A Comprehensive Study.
Muhsin Samet Yücel, İsmail Akçok

Med Chem· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Characterization of Anatolian Water Buffalo Rumen-Derived Bacterial Thermostable Xylanases: A Sequence-Based Metagenomic Approach.
Halil Kurt, Dilek Sever Kaya, İsmail Akçok, Ceyhun Sarı, Ebru Albayrak

ACS Omega· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapamycin and Niacin combination induces apoptosis and cell cycle arrest through autophagy activation on acute myeloid leukemia cells.
Lale Beril Subay, Emel Başak Gencer Akçok, İsmail Akçok

Mol Biol Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of promising inhibitors for N-SH2 domain of SHP2 tyrosine phosphatase: an in silico study.
Emel Başak Gencer Akçok, Hüseyin Güner, İsmail Akçok

Mol Divers· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethacrynic acid and cinnamic acid combination exhibits selective anticancer effects on K562 chronic myeloid leukemia cells.
Münevver Yenigül, İsmail Akçok, Emel Başak Gencer Akçok

Mol Biol Rep· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new drug testing platform based on 3D tri-culture in lab-on-a-chip devices.
Begum Gokce, Ismail Akcok, Ali Cagir, Devrim Pesen-Okvur

Eur J Pharm Sci· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiproliferative activity of (R)-4'-methylklavuzon on hepatocellular carcinoma cells and EpCAM/CD133 cancer stem cells via SIRT1 and Exportin-1 (CRM1) inhibition.
Murat Delman, Sanem Tercan Avcı, İsmail Akçok, Tuğçe Kanbur, Esra Erdal

Eur J Med Chem· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Multifunctional Hybrid Analogs for Stilbenes, Chalcones and Flavanones.
Ali Cagir, Burcu Odaci, Mehmet Varol, Ismail Akcok, Ozgur Okur

Anticancer Agents Med Chem· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRM1 inhibitory and antiproliferative activities of novel 4'-alkyl substituted klavuzon derivatives.
Tuğçe Kanbur, Murat Kara, Meltem Kutluer, Ayhan Şen, Murat Delman

Bioorg Med Chem· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Topoisomerase I inhibitory properties of klavuzon derivatives.
İsmail Akçok, Derya Mete, Ayhan Şen, Pınar Kasaplar, Kemal S Korkmaz

Bioorg Chem· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Rhodium Nanoparticle-Lewis Acidic Ionic Liquid Catalyst for the Chemoselective Reduction of Heteroarenes.
Alena Karakulina, Aswin Gopakumar, İsmail Akçok, Bastien L Roulier, Thomas LaGrange

Angew Chem Int Ed Engl· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of stilbene-fused 2'-hydroxychalcones and flavanones.
Ismail Akçok, Ali Cağir

Bioorg Chem· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis